EYEN — Eyenovia Income Statement
0.000.00%
Last trade - 00:00- $3.31m
- $11.14m
- $0.06m
Annual income statement for Eyenovia, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2 | 14 | 0 | 0.004 | 0.057 |
| Cost of Revenue | |||||
| Gross Profit | 1.2 | 12.4 | 0 | 0 | -3.87 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 21.8 | 26.4 | 26.9 | 25.4 | 48.8 |
| Operating Profit | -19.8 | -12.4 | -26.9 | -25.4 | -48.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.8 | -12.8 | -28 | -27.3 | -49.8 |
| Net Income After Taxes | -19.8 | -12.8 | -28 | -27.3 | -49.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.8 | -12.8 | -28 | -27.3 | -49.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.8 | -12.8 | -28 | -27.3 | -49.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -75.1 | -40.2 | -66.6 | -53.1 | -46.4 |